A detailed history of Camden National Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Camden National Bank holds 5,828 shares of ABT stock, worth $693,240. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,828
Previous 6,300 7.49%
Holding current value
$693,240
Previous $654,000 1.53%
% of portfolio
0.1%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $47,233 - $55,757
-472 Reduced 7.49%
5,828 $664,000
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $258,070 - $288,071
2,562 Added 68.54%
6,300 $654,000
Q1 2024

Apr 30, 2024

SELL
$109.52 - $120.96 $46,765 - $51,649
-427 Reduced 10.25%
3,738 $424,000
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $28,950 - $35,438
-321 Reduced 7.16%
4,165 $458,000
Q3 2023

Nov 03, 2023

SELL
$95.53 - $114.62 $14,425 - $17,307
-151 Reduced 3.26%
4,486 $434,000
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $9,674 - $10,779
96 Added 2.11%
4,637 $505,000
Q1 2023

May 08, 2023

SELL
$96.86 - $114.01 $159,044 - $187,204
-1,642 Reduced 26.56%
4,541 $459,000
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $42,777 - $50,184
-450 Reduced 6.78%
6,183 $679,000
Q3 2022

Nov 04, 2022

SELL
$96.76 - $112.03 $4,354 - $5,041
-45 Reduced 0.67%
6,633 $642,000
Q2 2022

Aug 09, 2022

SELL
$102.07 - $123.37 $83,187 - $100,546
-815 Reduced 10.88%
6,678 $726,000
Q1 2022

May 05, 2022

SELL
$114.02 - $139.04 $27,820 - $33,925
-244 Reduced 3.15%
7,493 $887,000
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $6,469 - $7,921
-56 Reduced 0.72%
7,737 $1.09 Million
Q3 2021

Nov 09, 2021

SELL
$116.66 - $129.06 $26,131 - $28,909
-224 Reduced 2.79%
7,793 $921,000
Q2 2021

Aug 09, 2021

BUY
$105.79 - $124.53 $38,084 - $44,830
360 Added 4.7%
8,017 $929,000
Q1 2021

Aug 04, 2021

SELL
$108.84 - $128.23 $5,442 - $6,411
-50 Reduced 0.65%
7,657 $918,000
Q4 2020

Feb 01, 2021

BUY
$105.0 - $114.42 $11,970 - $13,043
114 Added 1.5%
7,707 $844,000
Q3 2020

Nov 05, 2020

BUY
$91.64 - $111.29 $65,430 - $79,461
714 Added 10.38%
7,593 $826,000
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $1,531 - $1,960
-20 Reduced 0.29%
6,879 $629,000
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $4,837 - $7,073
-77 Reduced 1.1%
6,899 $544,000
Q4 2019

Feb 11, 2020

SELL
$78.51 - $87.4 $51,895 - $57,771
-661 Reduced 8.66%
6,976 $606,000
Q3 2019

Oct 11, 2019

BUY
$81.84 - $88.74 $95,425 - $103,470
1,166 Added 18.02%
7,637 $639,000
Q2 2019

Aug 08, 2019

SELL
$72.88 - $85.0 $9,765 - $11,390
-134 Reduced 2.03%
6,471 $544,000
Q1 2019

May 08, 2019

SELL
$66.22 - $80.06 $4,635 - $5,604
-70 Reduced 1.05%
6,605 $528,000
Q4 2018

Feb 04, 2019

BUY
$65.56 - $74.27 $24,191 - $27,405
369 Added 5.85%
6,675 $483,000
Q3 2018

Nov 08, 2018

SELL
$60.81 - $73.36 $9,425 - $11,370
-155 Reduced 2.4%
6,306 $463,000
Q2 2018

Aug 10, 2018

BUY
$57.57 - $63.54 $4,029 - $4,447
70 Added 1.1%
6,461 $394,000
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $1,406 - $1,590
-25 Reduced 0.39%
6,391 $383,000
Q4 2017

Feb 12, 2018

SELL
$53.68 - $57.47 $201,783 - $216,029
-3,759 Reduced 36.94%
6,416 $366,000
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $489,010 - $545,787
10,175
10,175 $543,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Camden National Bank Portfolio

Follow Camden National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Camden National Bank with notifications on news.